Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of inducing an anti-HIV-1 immune response comprising administering a C5/TM-GP41 peptide dimer

Method of inducing an anti-HIV-1 immune response comprising administering a C5/TM-GP41 peptide dimer

US Patent 10335482 · Granted Jul 2, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptides derived from viral proteins for use as immunogens and dosage reactants2019
Peptides derived from viral proteins for use as immunogens and dosage reactants2019
Peptides derived from viral proteins for use as immunogens and dosage reactants2019
Peptides derived from viral proteins for use as immunogens and dosage reactants2019
Method for reducing HIV-1 reservoir size using multivalent immunogen and reservo2019
Method for reducing HIV-1 reservoir size using multivalent immunogen and reservo2019
Method for reducing HIV-1 reservoir size using multivalent immunogen and reservo2019
Method for the vaccination against HIV2018
Method for the vaccination against HIV2018
Method for the vaccination against HIV2018
Dimeric scaffold proteins comprising HIV-1 GP120 and GP41 epitopes2016
Dimeric scaffold proteins comprising HIV-1 GP120 and GP41 epitopes2016